U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Accelerating Anticancer Agent Development and Validation Workshop (AAADV)
  1. Drugs

Accelerating Anticancer Agent Development and Validation Workshop (AAADV)

Accelerating Anticancer Agent Development and Validation Workshop (AAADV)

Goals and Objectives:

  1. To expedite the development and validation processes for new anticancer and cancer prevention agents.
  2. To educate investigators, so new agents may be made available to patients at a more efficient rate more rapidly in the future.
  3. To improve understanding of cancer drug development strategies to lead to a series of pivotal clinical trials demonstrating efficacy and patient benefit.

Who Should Attend:

  • Industry: Registrants should be involved in drug development.
  • Government: Registrants should be employed by an U.S. government agency and be involved in oncology drug discovery or development.
  • Academic: Registrants should be employed by a recognized academic institution and be involved or have an interest in oncology drug discovery and/or development. Previous or current experience in the conduct of clinical trials is helpful, but not required.
  • Advocates: Consumer and/or patient advocates should be sponsored by a nationally recognized advocacy organization or foundation. Advocates should have a background in clinical trial design and the role of the advocate in the development process.

Registration:

ww.acceleratingworkshop.orgdisclaimer icon

Contact

If to Duke:

If to FDA:

  • Jura Viesulas, MS, EdD
    Office of Hematology and Oncology Products
    Bldg. 22 Room 2200
    10903 New Hampshire Avenue
    Food and Drug Administration
    Silver Spring, MD 20993
    jura.viesulas@fda.hhs.gov